Increased GDF15 levels are observed in both cirrhosis and HCC stages [52] and these high levels at the cirrhotic stage may be ‘carried forward’ to the HCC stage that may contribute to the observed hepcidin downregulation in HCC. The gene discussed is HAMP; the disease is hepatocellular carcinoma.